Penn Medicine Provider
Breast Surgery
Jennifer Q. Zhang, MD
5.0
(140)
Accepting new patients
Sees patients age 18 and up
Penn Breast Surgery Perelman
Make an appointmentCall 215-615-2992

About me

  • Assistant Professor of Surgery at the Hospital of the University of Pennsylvania

Dr. Zhang’s clinical practice focuses on both benign and malignant breast surgery, with a specific clinical interest in locally advanced/inflammatory and estrogen receptor positive breast cancers. 

A graduate of Johns Hopkins University School of Medicine, Dr. Zhang completed a residency in general surgery at Beth Israel Medical Center in Boston, and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York.

In addition to her practice, Dr. Zhang conducts research centered around understanding the role of tumor-associated macrophages and dendritic cells in breast cancer and how to target these cells to improve breast cancer therapies. Dr. Zhang’s research is a collaboration with the laboratory of Robert Vonderheide, MD, DPhil, Director of the Abramson Cancer Center.

Education and training

  • Medical School: Johns Hopkins University School of Medicine
  • Residency: Beth Israel Deaconess Medical Center
  • Fellowship: Memorial Sloan-Kettering Cancer Center

What my patients think about me

Average Rating
5.0

140 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
very professional
May 2025
5.0
5.0
she was very knowledgeable, and took the time to explain and answer questions
May 2025
5.0
5.0
when offered another caregiver i chose to stay with dr. jenny zhang.
May 2025
5.0
5.0
cause she told me everything i wanted here great news

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Zhang is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Iwai Y, Perez-Rojas S, Thomas SM, Tadros AB, Woodward SG, Zhang JQ, Elmore LC, Freedman GM, Tchou JC, Bleznak AD, Fayanju OM ASO Visual Abstract: Guideline-concordant surgical care for lobular versus ductal inflammatory breast cancer , Annals of Surgical Oncology: 2024 (Epub)

Iwai Y, Perez-Rojas S, Thomas SM, Tadros AB, Woodward SG, Zhang JQ, Elmore LC, Freedman GM, Tchou JC, Bleznak AD, Fayanju OM Guideline-concordant surgical care for lobular versus ductal inflammatory breast cancer , Annals of Surgical Oncology: 2024 (Epub)

Tidwell J, Maddipatla VM, Lam C, Vonderheide RV, Zhang JQ Agonistic CD40 increases infiltration and spatial organization of cytotoxic CD8 T cells in hormone receptor positive murine breast cancer , Poster presentation at the Society of Surgical Oncology Annual Meeting, Atlanta, GA: 2024

Maddipatla V, Zhang J CD40 Agonism activates dendritic cells and inhibits tumor growth in murine HR+ breast cancer , Oral presentation at the Academic Surgical Congress 2024, Washington, DC: 2024

Zhang J Mechanism of agonistic CD40 therapy in murine HR+ luminal breast cancer , Oral presentation at the Early-stage Surgeon Scientist Program II Fall 2023 Symposium, NIH, Bethesda, MD: 2023

Zhang JQ, Dos Anjos CH, Sevilimedu V, Crown A, Amoroso KA, Pilewskie ML, Robson ME, Gemignani ML Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease , Annals of Surgical Oncology, 30(12): 2023,6990-6999

Manik R, Grady CB, Elmore LC, Fieber JH, Freedman GM, Jankowitz RC, Tchou JC, Zhang JQ, Hubbard RA, Fayanju OM Temporal trends and factors associated with receipt of post-mastectomy radiation after neoadjuvant chemotherapy in women with cT3 breast cancer , Annals of Surgical Oncology, 30(11): 2023,6506-6515

Pichardo MS, Zhang JQ, Fayanju OM Will targeted axillary surgery suffice for adjuvant treatment decision-making? , JAMA Surgery, 158(10): 2023,1021-1022

Rossi F, Liu M, Tieniber A, Etherington M, Hanna A, Vitiello G, Param N, Do K, Wang L, Antonescu C, Zeng S, Zhang JQ, DeMatteo RP Myosin light-chain kinase inhibition potentiates the antitumor effects of Avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor , Clinical Cancer Research, 29(11): 2023,2144-2157

Lanchoney O, Vonderheide RV, Zhang JQ Agonistic CD40 demonstrates anti-tumor efficacy and synergizes with immune checkpoint blockade in hormone receptor positive breast cancer , Poster presentation at the Translational Research Cancer Centers Consortium, Seven Springs, PA: 2023